Navigation Links
d'Oliveira & Associates Offers a New “No Win No Fee Promise” to Those Allegedly Injured from the Hair Loss Drug Propecia
Date:5/6/2013

(PRWEB) May 06, 2013

Alleging that the hair loss drug Propecia lead to his prolonged sexual dysfunction, an Illinois man filed a claim against Merck in Pennsylvania Eastern District Court (case no. 2:2013cv00659). According to court documents, on February 5th, 2013 the lawsuit was filed by the plaintiff on claims that Merck should have known the increased risk of side effects associated with Propecia such as sexual dysfunction.

The law firm of d’Oliveira & Associates is working with some of the leading Propecia lawyers in the country handling Propecia cases and want the public to know that they offer a “No Win No Fee Promise” for current or former Propecia users who have allegedly developed either breast or prostate cancer or suffered a permanent sexual dysfunction as a result of propeica use. This means that you would pay no legal fee unless and until you receive a settlement or award of your Propecia claim and or Propecia lawsuit.

ABC News reported in a July 2012 story that the popular hair-loss drug, Propecia, has been linked to its increases in its users developing permanent sexual dysfunctions (i). ABC News referenced a study that was published in the Journal of Sexual Medicine and conducted by researchers at George Washington University that found Propecia's use poses a significant threat to incompetence in its users. According to the study by the Journal of Sexual Medicine, Propecia’s side effects may persist for months or years after discontinuing use of the drug (ii).

Marketed by Merck & Co., Inc., Propecia is a commonly used drug meant to stop hair loss in men that was approved by The U.S. Food and Drug Administration (FDA) in 1997. In the 15 years since its approval, Propecia has been the center of several international studies examining the drug's link to

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. d'Oliveira & Associates Help New Bedford Woman Receive $95,000 in Damages for Dog Bite Injury Case #:NB-11736
2. d'Oliveira & Associates Helps Westport, MA Man Receive $100,000 Settlement for Reckless Driving Accident
3. d'Oliveira & Associates Helps Rhode Island Estate Receive the Maximum Compensation Under RI Law of $250,000 Settlement for Fatal Auto Accident
4. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
5. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
6. The Law Firm of d'Oliveira and Associates Now Offers a No Win - No Free Promise in Nexium Cases
7. d'Oliveira & Associates Notes the Announcement of Zoloft Birth Defects Multidistrict Litigation (MDL) Set to Start in Mid-September 2014
8. d'Oliveira & Associates Helps Fall River, MA Teenager Receive $38,500 in Auto Accident Settlement
9. D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
10. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
11. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 This is ... state of the Naproxen industry.The report provides a ... applications and industry chain structure. The Naproxen ... markets including development trends, competitive landscape analysis, and ... discussed as well as manufacturing processes and cost ...
(Date:5/29/2015)... 2015 The FSH Society ... science of the little-known and incurable disease, facioscapulohumeral ... the second FSHD Trial Preparedness Workshop. The Workshop, ... University of Rochester Medical Center in Rochester, New ... around the world, including representatives from industry, the ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report on H1 2015 pipeline ... data tables and 13 figures, spread across ...
(Date:5/29/2015)... For the third year, Nike Ultimate Camps will ... ultimate community an opportunity to experience ultimate training techniques in ... of the USAU Nike Ultimate Camp is to provide a ... character, and make lifelong friends. , The USAU Nike Ultimate ... skill and ability levels, ages 10-18. Camp will run from ...
(Date:5/29/2015)... 2015 A multi-center study led ... a urine test can determine if a patient ... Dr. James McKiernan presented these findings at the ... , Dr. McKiernan is the urologist-in-chief at ... chair of the Department of Urology at Columbia ...
Breaking Medicine News(10 mins):Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 3
... YORK, Aug. 27 Dr. Steven Victor, CEO of Las ... announce the airing of their infomercial promoting laser assisted liposuction. This is ... , , The laser makes the procedure of ... can virtually go back to work the next day with very little bruising ...
... , , , PHOENIX, Aug. 27 ... family members to serve as caregivers for older adults. Caregiving can be ... amazing gift to allow a loved one to "age in place" rather ... Medicare Advantage Plan, offers these seven secrets to success for caregivers of ...
... , , , ... has been named this year,s honorary chair for the Los Angeles Jewish ... one of the largest and most popular walks to take place each ... Sunday, December 6, in Reseda. , , ...
... Lifetime of Achievement Traces Arc of American Dream , , ... in New York City ... venture capitalist and philanthropist, will be Grand Marshal of the 2009 Columbus Day Parade in ... of Home Depot and chairman of the NYU Langone Medical Center, will lead contingents of ...
... SHANGHAI, Aug. 27 /PRNewswire-Asia/ -- Linkwell Corporation (OTC Bulletin,Board: ... in China, announced that its 90% held,subsidiary, Shanghai Likang ... of Likang -- The Establishment of One Hundred Model,Hospitals, ... to September,2010. , The COO ...
... , Former President Will Address Issues ... Aug. 27 Chicago House & Social Service Agency, the first organization ... HIV and AIDS, will host their first ever Speaker Series Luncheon on ... , The luncheon will feature a speech from President ...
Cached Medicine News:Health News:Seven Secrets to Successful Caregiving of Older Adults 2Health News:Award-Winning Actress and Director Anjelica Huston Selected as Honorary Chair for L.A. Jewish Home's 'Walk of Ages X' 2Health News:Award-Winning Actress and Director Anjelica Huston Selected as Honorary Chair for L.A. Jewish Home's 'Walk of Ages X' 3Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 2Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 3Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 4Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 2Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 3Health News:President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 2
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and ... AZN ) today announced that they have entered into ... preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, ... VEGF Receptor 2 antiangiogenic cancer medicine. The planned study ... with advanced solid tumors. The Phase I ...
(Date:5/29/2015)... , May 29, 2015 Educating ... of the Association for the Advancement of Wound ... With support from AAWC,s corporate partners, the ... Portal on the AAWC website at ... wound care pathway with links to various CME/CEU ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA ... financial results for the second quarter and three and six ... expressed in Canadian dollars and in accordance with International Financial ... ESSA recorded a net loss of $5.9 million ($0.35 ... 2015 (Q2-2015), compared to a net loss of $0.4 million ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... Presented at the 132nd Annual Meeting of the American Neurological ... Association in ... presented results from two,Phase III pivotal trials and one open-label ... restless legs,syndrome (RLS). These rotigotine data showed significant drops in ...
... Boehringer Ingelheim,Pharmaceuticals, Inc. today announced that ... full (traditional) approval of Aptivus(R),(tipranavir) capsules. The ... 2005; accelerated approval is a regulatory process ... or life-threatening illnesses. The full,approval of APTIVUS ...
Cached Medicine Technology:Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 2Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 3Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 4Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 5Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 2Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 3Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 4Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 5Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 6Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 7Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 8
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: